CI Jan 2026 490.000 call
| Previous Close | 5.60 |
| Open | 5.60 |
| Bid | 4.20 |
| Ask | 7.00 |
| Strike | 490.00 |
| Expire Date | 2026-01-16 |
| Day's Range | 5.60 - 5.60 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 4 |
- Yahoo Finance Video
FTC sues CVS, Cigna, UnitedHealth over rising insulin prices
The Federal Trade Commission (FTC) is suing pharmacy benefit managers CVS Health (CVS), Cigna Group (CI), and UnitedHealth (UNH) over insulin prices, claiming that they have been artificially inflating costs over the years. Yahoo Finance Senior Health Reporter Anjalee Khemlani joins Market Domination to break down the details of the story and why the price of insulin has risen so much. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Melanie Riehl
Barrons.comFTC Sues PBMs Over Insulin Prices, Citing a ‘Perverse System’
The FTC says the PBM units of CVS Health, Cigna, and UnitedHealth have inflated the price of insulin.
Associated Press FinanceHigh insulin prices spur a federal lawsuit against three pharmacy benefit managers
The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for diabetic patients. Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have engaged in anticompetitive practices that spur price increases, the Federal Trade Commission alleged in a lawsuit filed Friday.
